Stockholders' Equity (Tables)

3 Months Ended

Oct. 31, 2017

Stockholders' Equity Note [Abstract]

Schedule of Assumptions Used in the Valuation

The assumptions used in the valuation of options granted under the 2017 Plan during the three months ended October 31, 2017 are as follows:

	For the Three Months Ended October 31, 2017
Market value of stock on measurement date	$27.56 to $49.93
Risk-free interest rate	2.05% to 2.42%
Dividend yield	—	%
Volatility factor	327% to 329%
Term	10.00 years

The assumptions used in the valuation of the Pre-2017 Non-Qualified Stock Options for the three months ended October 31, 2017 and 2016 are as follows:

	2017			2016
Market value of stock on measurement date	$	36.79		$7.52 to $8.71
Risk-free interest rate	1.47		%	0.88% to 1.75%
Dividend yield	—		%	—	%
Volatility factor	96		%	114% to 348%
Term	2.12			3.03 to 10.00 years

Schedule of Options and Warrants Outstanding

Warrant activity for the three months ended October 31, 2017 is presented in the table below:

	Number of Shares		Weighted- average Exercise Price		Weighted- average Remaining Contractual Term (years)	Aggregate Intrinsic Value
Outstanding at July 31, 2017	768,800		$	12.50	3.04	$	1,184
Forfeited	(55,000	)	$	15.00
Outstanding at October 31, 2017	713,800		$	12.31	2.99	$	18,617
Exercisable at October 31, 2017	713,800		$	12.31	2.99	$	18,617

Stock option activity for options granted under the 2017 Plan during the three months ended October 31, 2017 is presented in the table below:

	Number of Shares		Weighted- average Exercise Price		Weighted- average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in Thousands)
Outstanding at July 31, 2017	—
Total Options authorized	400,000
Granted	(206,500	)	$	38.03
Expired	—
Forfeited	—
Options available at October 31, 2017	193,500
Outstanding at October 31, 2017	206,500		$	38.03	9.87	$	535
Exercisable at October 31, 2017	—

Stock option activity for the Pre-2017 Non-Qualified Stock Options for the three months ended October 31, 2017 is presented in the table below:

	Number of Shares		Weighted- average Exercise Price		Weighted- average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in Thousands)
Outstanding at July 31, 2017	3,770,000		$	8.13	6.87	$	19,140
Exercised	(10,000	)	$	10.00
Forfeited	(572,000	)	$	11.51
Outstanding at October 31, 2017	3,188,000		$	7.52	6.97	$	98,409
Exercisable at October 31, 2017	2,894,378		$	7.34	6.81	$	89,873

Schedule of Nonvested Share Activity

A summary of the status of the Company’s non-vested options granted under the 2017 Plan as of October 31, 2017 and changes during the three months ended October 31, 2017 are presented in the following table:

	Number of Shares		Weighted Average Grant Date Fair Value Per Share
Non-vested at July 31, 2017	—
Granted	(206,500	)	$	38.82
Vested	—
Non-vested at October 31, 2017	206,500		$	38.82

A summary of the status of the Company’s non-vested Pre-2017 Non-Qualified Stock Options as of October 31, 2017 and changes during the three months ended October 31, 2017 are presented below:

	Number of Shares		Weighted Average Grant Date Fair Value Per Share
Non-vested at July 31, 2017	339,871		$	7.93
Vested	(46,249	)	$	9.46
Non-vested at October 31, 2017	293,622		$	7.94